Market Tracker

05/25 5:16pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.70
Delayed Data
As of May 25
 -0.21 / -3.55%
Today’s Change
2.80
Today|||52-Week Range
10.80
+12.87%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close5.91
Today’s open5.93
Day’s range5.64 - 5.98
Volume1,130,894
Average volume (3 months)1,654,905
Market cap$625.4M
Dividend yield--
Data as of 4:00pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)+22.79%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book7.15

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.02-0.12%
SGYPSynergy Pharmaceutic...+0.01+0.28%
EPZMEpizyme Inc+0.11+1.03%
SCLNSciClone Pharmaceuti...+0.13+0.97%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts